XM无法为美国居民提供服务。

Omnicell soars after bullish quarterly report, outlook



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-Omnicell soars after bullish quarterly report, outlook</title></head><body>

** Shares in Omnicell Inc OMCL.O surging 33.9% on Wednesday, on track for record one-day pct gain after it reported Q3 EPS that soundly beat Wall St estimates and it increased its full year financial targets

** The provider of medication management, adherence tools for health systems and pharmacies reported adj EPS of $0.56 vs Wall St consensus expectation of $0.40 and reported rev of $282.42 mln vs avg est of $280.45 mln, as per LSEG

** OMCL forecast FY 2024 non-GAAP EPS between $1.65 and $1.72 vs previous target range announced on Aug 1 for FY EPS between $1.20 and $1.50 per share, while it sees total rev between $1.10 bln and $1.11 bln, up from previous target range of between $1.07 bln and $1.11 bln

** OMCL last traded at $53.64 vs median PT of $44.50, according to LSEG, which shows 9 analyst ratings: 1 'strong buy,; 3 'buy' and 5 'hold' ratings

** YTD the stock is up 42% vs gain of 8% for S&P 1500 health care sector index .SPCOMA


(Reporting By Sinéad Carew)

</body></html>

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明